The bacteriophage lambda cIII gene product permits lambda to enter the lysogeneic pathway by stabilizing the lambda cII regulatory protein. Several factors regulate cIII expression at the transcriptional level. It appears the also the initiation of translation of the cIII gene is subject to regulation. Analysis of a set of cIII-lacz gene and operon fusions demonstrated the presence of a sequence upstream of the cIII ribosome binding site that is required for cIII translation. This sequence contains an RNase III processing site. Expression of cIII is drastically reduced in cells lacking RNase III. Paradoxically, we found that unprocessed mRNA, but not processed RNA, can efficiently direct the translation of the cIII message. We proposed that the ribosome binding site of cIII is occluded by mRNA secondary structure. Initiation of cIII translation requires the presence of a sequence that is acted upon by RNase III. The function of RNase III is to expose the cIII ribosome binding site permitting initiation of translaton. This regulatory function of RNase III may be distinct from its action in the cleavage of mRNA; it is possible the mRNA binding per se by RNase III activates cIII translation. There are very few examples where positive translational control of gene expression is clearly demonstrated. Furthermore the laws that govern the recognition of specific RNA sites by RNA binding proteins such as RNase III are poorly understood. Genetic and biochemical approaches will be employed to study the mechanism of the regulation of cIII expression. A genetic system for the generation, selection and study of mutation in the regulatory site has been developed. Procedures for the selection of specific mutations in rnc are given. The biochemical approach includes the use of in vitro synthesized RNA that will be used for studies in the binding and processing by RNase III, in cIII translation by purified and crude translation systems, and in the characterization of mutations in rnc. Introduction of specific base alterations will be analyzed for their effects on gene expression and RNA secondary structure.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM038694-02
Application #
3295310
Study Section
Microbial Physiology and Genetics Subcommittee 2 (MBC)
Project Start
1988-08-29
Project End
1991-07-31
Budget Start
1989-08-01
Budget End
1990-07-31
Support Year
2
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Hebrew University of Jerusalem
Department
Type
DUNS #
600044978
City
Jerusalem
State
Country
Israel
Zip Code
91904
Oppenheim, A B; Kornitzer, D; Altuvia, S et al. (1993) Posttranscriptional control of the lysogenic pathway in bacteriophage lambda. Prog Nucleic Acid Res Mol Biol 46:37-49
Altuvia, S; Kornitzer, D; Kobi, S et al. (1991) Functional and structural elements of the mRNA of the cIII gene of bacteriophage lambda. J Mol Biol 218:723-33
Kornitzer, D; Altuvia, S; Oppenheim, A B (1991) Genetic analysis of the cIII gene of bacteriophage HK022. J Bacteriol 173:810-5
Oppenheim, A; Altuvia, S; Kornitzer, D et al. (1991) Translation control of gene expression. J Basic Clin Physiol Pharmacol 2:223-31
Kornitzer, D; Altuvia, S; Oppenheim, A B (1991) The activity of the CIII regulator of lambdoid bacteriophages resides within a 24-amino acid protein domain. Proc Natl Acad Sci U S A 88:5217-21
Kornitzer, D; Teff, D; Altuvia, S et al. (1991) Isolation, characterization, and sequence of an Escherichia coli heat shock gene, htpX. J Bacteriol 173:2944-53
Altuvia, S; Kornitzer, D; Teff, D et al. (1989) Alternative mRNA structures of the cIII gene of bacteriophage lambda determine the rate of its translation initiation. J Mol Biol 210:265-80
Kornitzer, D; Teff, D; Altuvia, S et al. (1989) Genetic analysis of bacteriophage lambda cIII gene: mRNA structural requirements for translation initiation. J Bacteriol 171:2563-72